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Linear ubiquitin chain assembly complex
coordinates late thymic T-cell differentiation and
regulatory T-cell homeostasis
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The linear ubiquitin chain assembly complex (LUBAC) is essential for innate immunity in
mice and humans, yet its role in adaptive immunity is unclear. Here we show that the
LUBAC components HOIP, HOIL-1 and SHARPIN have essential roles in late thymocyte
differentiation, FOXP3þ regulatory T (Treg)-cell development and Treg cell homeostasis.
LUBAC activity is not required to prevent TNF-induced apoptosis or necroptosis but is
necessary for the transcriptional programme of the penultimate stage of thymocyte
differentiation. Treg cell-speciﬁc ablation of HOIP causes severe Treg cell deﬁciency and
lethal immune pathology, revealing an ongoing requirement of LUBAC activity for Treg
cell homeostasis. These data reveal stage-speciﬁc requirements for LUBAC in coordinating
the signals required for T-cell differentiation.
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T
he thymus orchestrates the differentiation of
haematopoietic precursors into diverse T-cell sub-lineages.
These lineages include conventional T-cell receptor
(TCR)ab CD4þ and CD8þ T cells, Forkhead box-P3þ
(FOXP3þ ) regulatory T (Treg) cells, natural killer T (NKT)
cells, TCRgd T cells and CD8aa T cells. A major determinant of
cell fate is the speciﬁcity of the newly rearranged TCR for
major histocompatibility complex (MHC) or MHC-like
molecules presenting self-constituents, yet this stimulus alone is
not sufﬁcient to elaborate the many different T-cell types. T-cell
differentiation is also inﬂuenced by cytokine receptors, members
of the tumour necrosis factor receptor (TNFR) superfamily,
chemokine receptors and adhesion molecules. Yet, precisely
how these various cues are integrated to coordinate T-cell
differentiation is unclear.
Positive selection rescues double-positive (DP) thymocytes
from death-by-neglect and initiates the largest transcriptional
re-programming in T-cell differentiation1. The upregulation of
the C–C chemokine receptor type 7 (CCR7) mediates the
migration of thymocytes from the cortex to the medulla as
they differentiate into CD4þ or CD8þ single-positive (SP) cells.
During residency in the medulla2, SP thymocytes undergo
further maturation that involves a switch in TCR responses
from apoptosis to proliferation and acquisition of the capacity
to emigrate from the thymus3. Few of the stimuli that drive
this maturation are known, although the nuclear factor-kB
(NF-kB) pathway and interleukin (IL)-7 receptor signalling are
important3–5.
Treg cells are a potent immune modulatory subset of CD4þ
T cells that emerge during the late stage of thymocyte
differentiation6. The integration of cues from the TCR,
members of the TNFR superfamily and cytokine receptors
(mainly the IL-2 receptor) culminate in the expression of the
key transcription factor, FOXP3 (refs 7,8). The NF-kB signalling
pathway is critical for Treg cell differentiation, in particular,
c-REL is necessary to consolidate FOXP3 expression to enable
Treg cell proliferation6,7. In the periphery, Treg cells continue to
rely on TCR and co-stimulatory inputs for their proliferation and
differentiation into the various effector states that are required for
proper immune regulation9–11.
The linear ubiquitin chain assembly complex (LUBAC) is
composed of at least three proteins: ring ﬁnger protein 31
(RNF31/HOIP), RanBP-type and C3HC4-type zinc ﬁnger
containing 1 (RBCK1/HOIL-1) and SHANK-associated RH
domain interacting protein (SHARPIN/SIPL1)12. LUBAC can
regulate diverse cell signalling pathways by catalysing the
addition of linear ubiquitin chains to substrates. Innate and
adaptive immune responses depend on LUBAC activity
downstream of TNFR1, NOD2, TLR, NLRP3, TCR and B-cell
receptor ligation13,14. These signals involve the linear
ubiquitination of NEMO to reinforce canonical NF-kB
signalling, although it is likely to be that other LUBAC
substrates exist. Loss of LUBAC activity drives cells into
apoptosis or necroptosis following exposure to TNF,
lymphotoxin a or genotoxic stress15–19. All three LUBAC
components are required for maximal linear ubiquitination;
however, not all components are equal. Although HOIP
deﬁciency alone completely ablates LUBAC activity18,19,
SHARPIN-deﬁcient cells still display substantial linear
ubiquitination, because HOIL/HOIP complexes are able to
sustain signiﬁcant LUBAC function17–19. Consistent with these
observations, HOIP-deﬁcient mice are embryonic lethal18,
whereas the SHARPIN-deﬁcient mice from the chronic
proliferative dermatitis mutation (cpdm) strain (hereafter
referred to as Sharpincpdm mice) are born viable, but succumb
to severe dermatitis at 12–14 weeks of age20,21.
Patients with loss-of-function mutations in RBCK1 (encoding
HOIL-1) or RNF31 (encoding HOIP) exhibit impaired NF-kB
responses, defects in B-cell activation and hyper-responsiveness
of monocytes to IL-1b, the latter presumably driving auto-
inﬂammatory disease22,23. These patients also had evidence of
T-cell defects, including low thymic output and decreased
TCRabþ CD4þ and CD8þ T cells, which exhibit poor
proliferative responses to mitogens and antigens22,23, but
whether these defects represent T-cell intrinsic defects is unclear.
In this study, we examine the requirement for each LUBAC
component in T-cell and Treg cell lineages. The data reveal that
LUBAC components play pivotal roles in late thymocyte
differentiation of conventional T cells, non-conventional
T cells and Treg cell homeostasis. LUBAC activity is necessary
for the transcriptional programming of late thymocyte
differentiation. Consistent with the distinct requirements for
HOIL and HOIP versus SHARPIN in linear ubiquitination,
the T-cell defects observed are more severe with HOIL-1 or
HOIP deﬁciency compared with Sharpin deﬁciency. These data
highlight previously unappreciated roles for LUBAC in T-cell
biology.
Results
LUBAC activity is required for thymic T-cell differentiation.
To determine whether T-cell differentiation requires LUBAC
activity, we used loss-of-function genetic models for each of the
three known components. We used a Cd4Cre transgene to induce
conditional excision of loxP-ﬂanked alleles of Rnf31 (the gene
encoding HOIP) or Rbck1 (the gene encoding HOIL-1) to create
mice with T-lineage-speciﬁc deletion (hereafter termed HoipDCd4
or HoilDCd4, respectively). The role of the third LUBAC
component was investigated using Sharpincpdm mice, which lack
SHARPIN in all cells and were analysed before the development
of extensive skin pathology.
The peripheral immune organs of HoipDCd4 and HoilDCd4 mice
were almost completely devoid of CD8þ and CD4þ abTCRþ
T cells (Fig. 1a,b). Although the proportions of FOXP3þ Treg
cells among abTCRþ CD4þ T cells were normal in HoipDCd4
and HoilDCd4 mice, their number was greatly reduced, in
line with the overall T-cell deﬁciency (Fig. 1a,b). The residual
abTCRþ T cells in HoipDCd4 and HoilDCd4 mice were
predominantly CD44hi CD62Llo (Fig. 1c,d), suggestive of an
activated/effector phenotype that is often associated with
‘homeostatic’ expansion during lymphopenia24. By contrast, the
numbers, proportions and activation status of conventional
CD8þ and CD4þ T cells in Sharpincpdm mice were
comparable to controls (Fig. 1a–d). Consistent with recent
reports25,26, we observed that Treg cells were reduced in
Sharpincpdm mice, although to a much lesser extent compared
with the HoipDCd4 and HoilDCd4 mice (Fig. 1a,b). These data
indicate that the LUBAC components HOIL-1 and HOIP are
necessary for conventional CD4þ and CD8þ T-cell
differentiation, and that SHARPIN is dispensable.
This differential requirement for LUBAC components
extended to non-conventional T cells. CD1d-dependent NKT
cells are potent immune modulatory T cells that can be detected
by staining with a-galactosylceramide-loaded CD1d tetramers.
NKT cells were virtually undetectable in the spleen and lymph
nodes of HoipDCd4 and HoilDCd4 mice, yet they could be
recovered from Sharpincpdm mice (albeit in reduced numbers
compared to controls) (Fig. 1e,f and data not shown). Normal
numbers of gdTCRþ T cells were found in Sharpincpdm mice
(and, as expected, in HoipDCd4 and HoilDCd4 mice, as Cd4Cre only
becomes active after divergence of the abTCR and gdTCR T cell
lineages; Supplementary Fig. 1).
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We tracked the origin of these T-cell defects to the thymus.
The proportions of CD4þ and CD8þ SP thymocytes were
signiﬁcantly reduced in HoipDCd4 and HoilDCd4 mice but were
found to be normal in Sharpincpdm mice (Fig. 2a,b and
Supplementary Fig. 2). By contrast, the proportions and numbers
of FOXP3þ Treg cells among CD4SP thymocytes were greatly
diminished in all three strains, as were the CD25þ FOXP3 and
CD25 FOXP3þ thymic Treg cell precursors (Fig. 2a,b). These
data demonstrate that all three LUBAC components are required
for the earliest checkpoint in Treg cell differentiation. NKT cells
were almost undetectable in the thymus of HoipDCd4 and
HoilDCd4 mice but were present in normal numbers in
Sharpincpdm mice (Fig. 2c,d), demonstrating that this lineage
has a dependency on LUBAC similar to that of conventional
abTCR T cells.
Late-stage thymocyte differentiation requires HOIL-1 and HOIP.
To parse out thymocyte differentiation following positive
selection, we employed a staging scheme validated by
Mingueneau et al.1 (schematically represented in Fig. 3a),
comparing expression of the early activation marker CD69 and
the mature SP marker MHC class I (MHC I, H2-Kb). The
proportions of pre-selection (CD69 MHC Ilow) and early
selection thymocytes (CD69low/high MHC Ilow) were comparable
among all strains (Fig. 3b), with normal numbers of
CD4þCD8low/intermediate cells27 progressing through
differentiation (Supplementary Fig. 3). However, both HoipDCd4
and HoilDCd4 mice exhibited speciﬁc loss of the late selection/
mature subsets (CD69high MHC Ihigh and CD69low MHC Ihigh,
termed Fractions 4 and 5, ref. 1), Fig. 3b and Supplementary
Fig. 3). This defect corresponded to the loss of ‘mature’ CD24low
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Figure 1 | Absence of HOIP or HOIL-1 causes T-cell deﬁciency. (a) Flow cytometry of splenic cells from 7- to 15-week-old control, HoipDCd4, HoilDCd4 and
Sharpincpdm assessed for expression of TCRb (top panels), CD4 and CD8 (middle panels), and for FOXP3, after gating on CD4þ cells (bottom panels).
(b) Quantiﬁcation of CD4þCD8þTCRbþ and CD4þFOXP3þ cells in the spleen. (c) Surface expression of CD44 and CD62L on CD4þFOXP3
(top panels) and CD8þ T cells (bottom panels) in spleens of control, HoipDCd4, HoilDCd4 and Sharpincpdm mice. (d) Absolute numbers of CD44high
CD62Llow activated cells in the CD4þFOXP3 (left graph) and CD8þ (right graph) populations from the spleens of controls, HoipDCd4, HoilDCd4 and
Sharpincpdm mice. (e) Flow cytometry of splenic CD1d-aGalCer tetramer-positive NKT cells from 7- to 15-week-old control, HoipDCd4, HoilDCd4 and
Sharpincpdm mice. (f) Total cell numbers and percentages of CD1d-a-galactosylceramide (a-GalCer) tetramer-positive NKTcells in the spleen. For b,d and f,
each symbol represents an individual mouse; small horizontal lines indicate mean±s.d.; *Po0.05, **Po0.01, ***Po0.005 and ****Po0.001, respectively.
One-way analysis of variance with a Tukey’s post-hoc test for multiple comparisons was used for statistical analysis. Shpncpdm refers to Sharpincpdm mice.
Data are pooled from six independent experiments with two to six mice per group (a–d) or representative of two independent experiments with three to six
mice per group (e,f).
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CD62Lhigh CCR7þ / CD4SP (Fig. 3c,d and Supplementary
Fig. 3). By contrast, thymocytes from Sharpincpdm mice exhibited
largely normal progression through these differentiation stages
(Fig. 3b–e). These data establish that, in the absence of HOIL-1 or
HOIP, early positive and negative selection events occur normally,
but that SP thymocyte maturation is almost completely blocked.
Positively selected thymocytes upregulate the chemokine
receptor CCR7 and migrate into the medulla, where a second
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Figure 2 | Thymic T-cell differentiation in LUBAC-deﬁcient mice. (a) Surface staining of CD4 and CD8 (upper panels), and FOXP3 and CD25 (lower
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‘wave’ of thymocyte selection and differentiation of FOXP3þ
Treg cells occurs7,28. High expression of the transcription
factor HELIOS in FOXP3 CCR7þ CD4SP identiﬁes
thymocytes destined for either deletion (negative selection)
or early differentiation into the Treg cell lineage following
high-avidity TCR stimulation29. We noted a marked reduction in
the proportions and numbers of HELIOShigh FOXP3 CCR7þ
CD4SP in HoipDCd4, HoilDCd4 and Sharpincpdm mice compared
with controls (Fig. 3f). However, CD5 levels (a surrogate marker
of TCR signal strength) in mice lacking LUBAC components
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were comparable to those seen in controls (data not shown).
These data suggest that the reduction in HELIOShigh FOXP3
CCR7þ CD4SP cells in mice lacking LUBAC components was
not associated with altered TCR signal strength but rather
impaired induction of differentiation programmes parallel to or
downstream of high-avidity TCR signals.
Interactions between maturing thymocytes and thymic
epithelial cells are essential for the induction of a normal thymic
medulla, primarily via the provision of ligands for members
of the TNFR superfamily that are expressed by the epithelium30.
To investigate the possibility that defects in the thymic
microenvironment might contribute to the block in SP
thymocyte differentiation observed in HoipDCd4 and HoilDCd4
mice, we created irradiation chimeras reconstituted with
50:50 mixtures of haematopoietic precursors from the mutant
mice with CD45.1þ congenically marked wild-type (WT) mice.
Although the double-negative (DN) and DP thymocyte
precursor populations showed B40–50% representation of
the CD45.2þ HoipDCd4 or HoilDCd4 compartments, there
was a speciﬁc loss of CD45.2þ cells at the CD8SP, CD4SP
CCR7þ ‘wave 2’ and FOXP3þ Treg cell stages (Fig. 3g).
Virtually, no HOIP- or HOIL-1-deﬁcient T-lineage cells were
detected in the periphery of these chimeras (Fig. 3g). These
data demonstrate that the requirement for LUBAC activity is
T-cell intrinsic.
We then tested whether LUBAC deﬁciency was causing
apoptosis of SP thymocytes. LUBAC activity might be required
to prevent induction of pro-apoptotic BH3-only proteins or to
upregulate pro-survival BCL-2 proteins downstream of TCR
signalling31, or in response to DNA damage15. Therefore, we
tested whether the complete ablation of the mitochondrial
pathway of apoptosis would rescue T-cell differentiation in
HoipDCd4 mice. The multi-BH domain pro-apoptotic BCL-2
family proteins BAX and BAK are essential for the mitochondrial
outer membrane permeabilization that executes this pathway of
apoptosis32. Extensive redundancy between BAX and BAK,
and the early lethality observed in Bax /Bak / mice
necessitated conditional deletion of Bax using Cd4Cre on a
Bak / background to induce T-cell-speciﬁc ablation of the
mitochondrial pathway of apoptosis. As expected, the DN block
observed in Bax /Bak / haematopoietic chimeras33 was
bypassed in BaxDCd4Bak / mice, yet expansion of CD4SP,
CD8SP and mature DN thymocytes, and increased percentages of
peripheral T cells were observed (Fig. 3h). The compound loss of
BAX and BAK in HoipDCd4 mice did not restore late-stage
thymocyte differentiation or peripheral T cells (Fig. 3h and data
not shown). These data indicate that LUBAC was neither
required to antagonize thymocyte deletion nor to transduce
pro-survival signals to block the mitochondrial apoptotic
pathway.
NF-jB signalling is partially impaired by LUBAC deﬁciency.
Previous studies found that LUBAC is critical for optimal NF-kB
activation downstream of immune receptor signalling in
B-cell lymphomas and Jurkat T cells by associating with the
CARD11/BCL-10/MALT1 (CBM) complex34,35. Therefore, we
compared the kinetics and extent of activation of the NF-kB
pathway following CD3/CD28 stimulation of thymocytes from
HoilDCd4, Sharpincpdm and control mice. The degradation of
inhibitor of kBa (IkBa) is a hallmark of NF-kB activation and
was apparent within 0.5 h of CD3/CD28 stimulation of control
thymocytes (Fig. 4a). However, in CD3/CD28-stimulated
thymocytes from HoilDCd4 mice, IkBa degradation was
delayed (Fig. 4a), suggesting that loss of this LUBAC
component caused defects in NF-kB activation. By contrast, the
kinetics of p38 mitogen-activated protein kinase phosphorylation
following CD3/CD28 stimulation of HoilDCd4 and Sharpincpdm
thymocytes was comparable to controls (Fig. 4a). Although
these data show that LUBAC is involved in transducing
TCR-dependent NF-kB signals in thymocytes, this defect is
unlikely to explain the block in late-stage thymocyte
differentiation observed in HoilDCd4 and HoipDCd4 mice. Loss
of CARD11, BCL10 or MALT1 completely blocks NF-kB
activation following TCR stimulation of thymocytes, yet these
defects do not impair conventional T-cell development
(for example, see ref. 36). Collectively, these ﬁndings suggest a
requirement for LUBAC in thymocyte differentiation beyond
NF-kB activation downstream of TCR and the CBM complex.
Therefore, we tested whether LUBAC was also required in
thymocytes for NF-kB activation downstream of stimulation of
TNFR family members. TNF stimulation of WT thymocytes
induced phosphorylation of p65 (RELA) within 5min and
degradation of IkBa within 15min (Fig. 4b). HOIL-1 or HOIP
deﬁciency reduced and delayed TNF-induced p65
phosphorylation and IkBa degradation (Fig. 4b). Although
TNF-stimulated thymocytes from HoilDCd4 and HoipDCd4 mice
exhibited similar kinetics of p38 mitogen-activated protein kinase
phosphorylation, the overall levels appeared to be lower than in
control cells (Fig. 4b). Collectively, these data reveal a
requirement for LUBAC activity in optimal NF-kB activation
downstream of both TCR and TNFR ligation.
To determine whether enforced NF-kB activation could
rescue the thymic defects observed in HoipDCd4 mice, we
Figure 3 | SP thymocyte differentiation and survival in LUBAC-deﬁcient mice. (a) Schematic representation of CD4þ T-cell development in the thymus.
Earliest thymic progenitor (ETP) cells undergo progressive differentiation from DN to DP to single-positive (CD4 or CD8) cell. The different stages of
thymocyte development are also accompanied by changes in CD24, CD62L, CCR7, CD69 and MHC I (H2-Kb) surface marker expression on the
differentiating thymocyte. (b) Flow cytometric analysis of the surface expression of MHC I (H2-Kb) versus CD69 on whole thymocytes from 7- to
15-week-old control, HoipDCd4, HoilDCd4 and Sharpincpdm mice. (c) Quantiﬁcation of total cell numbers and percentages of Fraction 4 (MHC Ihigh CD69high)
and Fraction 5 (MHC Ihigh CD69low) populations for control, HoipDCd4, HoilDCd4 and Sharpincpdm mice. Surface expression of CD24 versus CD62L (d),
CD24 versus CCR7 (e), Helios versus CCR7 (f) gated on CD4SP from 7- to 15-week-old control, HoipDCd4, HoilDCd4 and Sharpincpdm mice. Right, cell
numbers of the mature CD24low CD62Lhigh, CD24low CCR7high and HELIOShigh CCR7high from CD4SP cells. (g) Contribution to different thymic T cell
subsets in 50:50 mixed bone marrow chimeras 8 weeks after reconstitution. Columns show percentage of WT CD45.1þ (white bar) and CD45.2þ control,
HoipDCd4, HoilDCd4 and Sharpincpdm (black bar) cells in individual chimeric mice. DN; CD4CD8 , DP; CD4þCD8þ SP3; CD4þCD24lowCCR7high, W1;
CD4þCCR7low,HELIOSþ , W2; CD4þCCR7high,HELIOSþ , Treg; CD4þFOXP3þ . Each bar represents an individual mouse. (h) Surface expression of CD4
and CD8 on whole thymocytes (upper panels) and B220 and TCRb on splenocytes (lower panels) from control, BaxDCd4Bak / , HoipDCd4 and
HoipDCd4BaxDCd4Bak / mice. For c,d,e and f, each symbol represents an individual mouse; small horizontal lines indicate mean±s.d.; *Po0.05,
**Po0.01, ***Po0.005 and ****Po0.001, respectively. One-way analysis of variance with a Tukey’s post-hoc test for multiple comparisons was used for
statistical analysis. Shpncpdm refers to Sharpincpdm mice. Data are pooled from six independent experiments with two to six mice per group (b–f) or
representative of two independent experiments with four to six mice per group (g), or representative of two independent experiments with one to ﬁve mice
per group (h).
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introduced a Cre-inducible allele of mutant Ikbkb that encodes a
constitutively active form of IKK2 (IKKca) when expressed37.
Although the proportions of CD4SP and CD8SP remained
low in HoipDCd4IKKca mice, the proportions of mature
CD4þCD24lowCD62high cells and FOXP3þ cells were restored
to levels observed in control mice (Fig. 4c). Nevertheless,
HoipDCd4IKKca mice had severe T-cell deﬁciency in the
periphery (Fig. 4d). This outcome indicates that the
reinforcement of NF-kB signalling in LUBAC-deﬁcient T cells
only partially rescues the block in late-stage T-cell differentiation,
and that other cell survival or differentiation programmes must
also rely on LUBAC.
LUBAC does not antagonize TNF-induced killing of thymocytes.
Impaired LUBAC function can switch pro-survival TNFR1
signalling into caspase-8-dependent apoptosis or caspase-
independent, RIPK1/RIPK3/MLKL-mediated necroptosis17,38,39.
TNF is produced constitutively in the thymic medulla by
epithelial cells and dendritic cells8, prompting the hypothesis that
LUBAC deﬁciency might lead to the death of medullary SP and
Treg cells. Surprisingly, we found that TNF treatment of
thymocytes from HoipDCd4, HoilDCd4 and Sharpincpdm mice did
not induce greater cell death than observed in control thymocytes
(Fig. 5a). Moreover, treatment of cells with TNF plus a small
molecular mimetic of second mitochondria-derived activator of
caspases (SMACs) did not induce additional death of HoipDCd4,
HoilDCd4 and Sharpincpdm thymocytes. Similarly, when
TNF/SMAC mimetic-induced cell death was blocked by the
caspase inhibitor, QVD-OPh, to engage the alternative cell
death mechanism, necroptosis, the viability of thymocytes from
HoipDCd4, HoilDCd4 and Sharpincpdm mice was comparable to WT
thymocytes (Fig. 5a). Necroptosis is dependent on the activities of
RIPK1, RIPK3 and the pseudo-kinase MLKL. Blocking necroptosis
using the RIPK1 inhibitor necrostatin-1 did not alter the survival of
thymocytes from HoipDCd4, HoilDCd4 or Sharpincpdm mice in vitro.
These data do not support the notion that LUBAC deﬁciency
sensitizes thymocytes to TNF-induced cell death.
We also tested this hypothesis in vivo by analysing whether the
loss of thymic Treg cells in Sharpincpdm mice could be rescued
by genetic ablation of TNF or critical cell death inducers.
Tnf / Sharpincpdm mice are protected from multi-organ
inﬂammation19, but the ﬁvefold reduction in thymic Treg cells
caused by SHARPIN deﬁciency was not restored by loss of TNF
(Fig. 5b,c). However, lymphotoxin a can serve as an alternative
ligand for TNFR1 and is also extensively expressed in the thymic
medulla. Formation of the death-inducing complex II following
TNFR1 ligation can initiate caspase-8-dependent apoptosis or,
when caspases are inhibited, RIPK3- and MLKL-dependent
necroptosis40. Although normal differentiation of thymic Treg
cells was observed in Mlkl / and Mlkl /Casp8 / mice,
the reduction of thymic Treg cells caused by SHARPIN deﬁciency
was not corrected in SharpincpdmMlkl /Casp8 / mice
(Fig. 5b,c). Likewise, loss of Ripk3 and Casp8 haploinsufﬁciency
failed to rescue the thymic Treg cell defects in Sharpincpdm mice
(Fig. 5b,c).
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Figure 4 | Perturbed TCR or TNFR signalling in LUBAC-deﬁcient
thymocytes. Immunoblot analysis of phosphorylated (activated) p38,
phosphorylated (activated) p65 or total IkBa from thymocytes left
unstimulated (0) or stimulated with anti-CD3/CD28 for 0.5, 1, 3 or 5 h (a)
or with TNF for 5, 15, 30 or 60min (b). (c) Surface staining of CD4 and
CD8 (upper panels), CD24 and CD62L gated on CD4þ cells (middle
panels), CD3 and FOXP3 gated on CD4þ cells (lower panels) and
numerical quantiﬁcation of thymocytes from 7- to 15-week-old control,
HoipDCd4 and HoipDCd4IKKca mice. (d) Surface expression of CD4 and CD8
(upper panels), TCRb and FOXP3 (lower panels) on splenocytes from
control, HoipDCd4 and HoipDCd4IKKca mice. For a and b, data are
representative of two independent experiments with one mouse per group.
For c and d, each symbol represents an individual mouse; small horizontal
lines indicate mean±s.d.; *Po0.05, **Po0.01, ***Po0.005 and
****Po0.001, respectively. One-way analysis of variance with a Tukey’s
post-hoc test for multiple comparisons was used for statistical analysis.
Data are pooled from three independent experiments with two to ﬁve mice
per group (c,d).
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To test whether the block in conventional thymocyte differ-
entiation observed in HoipDCd4 mice was caused by complex
II-mediated apoptotic cell death, we generated HoipDCd4
Casp8DCd4Mlkl / mice. Genetic ablation of caspase-8-mediated
apoptosis and MLKL-mediated necroptosis failed to restore normal
SP thymocyte differentiation or peripheral T-cell numbers in
HoipDCd4 mice (Fig. 5d). Collectively, these data demonstrate that
LUBAC is not solely required to prevent apoptotic or necroptotic
cell death in medullary thymocytes, but rather must be necessary
for a process that is critical for the differentiation of maturing
thymocytes.
LUBAC is required for transcriptional programming of T cells.
To identify the impact of LUBAC deﬁciency on the transcriptional
programme of thymocyte differentiation immediately following
positive selection, we ﬂuorescence-activated cell sorting (FACS)
puriﬁed lineage-depleted CD69þ MHC Ilow and CD69þ MHC
Ihigh thymocytes (Fractions 3 and 4; ref. 1) fromWT, HoilDCd4 and
Sharpincpdm mice, and subjected them to RNA sequencing. These
populations were selected because: (1) this transition is associated
with consolidation of the large transcriptional changes that follow
positive selection1; (2) the subset composition of these fractions,
deﬁned by CD4 and CD8 expression, was comparable among mice
of the different genotypes (Supplementary Fig. 3); and (3) this
transition immediately precedes the loss of mature SP observed in
the HoilDCd4 and HoipDCd4 mice (Fig. 3a).
HOIL deﬁciency altered the transcriptome immediately
following positive selection (124 differentially expressed genes
in CD69þ MHC Ilow thymocytes) and this effect was ampliﬁed in
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Figure 5 | Inhibition of cell death in LUBAC-deﬁcient thymocytes. (a) Cell death determined by PI uptake in thymocytes from control, HoipDCd4, HoilDCd4 and
Sharpincpdm mice cultured for 24h with combinations of agonists (T: 100ngml 1 TNF; S: 500nM SMAC mimetic; Q:10mM QVD-OPh;N: 10mM necrostatin).
Percentages (b) and absolute numbers (c) of CD4þFOXP3þ cells in the thymus of WT (n¼ 18), Sharpincpdm (n¼ 11), Mlkl / (n¼4), Mlkl /Casp8 /
(n¼4), SharpincpdmCasp8 /Mlkl / (n¼4), Rip3k /Casp8þ / (n¼4), SharpincpdmRip3k /Casp8þ / (n¼4), Tnf/ (n¼4) and
SharpincpdmTnf/ (n¼ 5) mice. Shpncpdm refers to Sharpincpdm mice. (d) Surface expression of CD4 and CD8 on whole thymocytes from control,
Casp8DCd4Mlkl / , HoilDCd4 and HoipDCd4Casp8Dcd4Mlkl /mice. Data are representative of two independent experiments with one mouse per genotype
(a,d). For b and c, each symbol represents an individual mouse, with 4–14 mice per group; small horizontal lines indicate mean±s.d.; *Po0.05, **Po0.01,
***Po0.005 and ****Po0.001, respectively. One-way analsyis of variance with a Tukey’s post-hoc test for multiple comparisons was used for statistical analysis.
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CD69þ MHC Ihigh thymocytes (724 differentially expressed
genes; Fig. 6a). Surprisingly, thymocytes from Sharpincpdm mice
had more substantial alteration of the transcriptome, perhaps
reﬂecting the consequences of moderate LUBAC defects
throughout T-cell differentiation (compared with the conditional
deletion of HOIL-1 at the DP stage) and minor differences in the
genetic background (still largely C57BL/Ka versus WT C57BL/6).
To analyse the transcriptional changes associated with the block
in SP thymocyte differentiation, we performed a heat-map
analysis of the most signiﬁcantly upregulated (25) or down-
regulated (50) genes in CD69þ MHC Ilow and CD69þ MHC
Ihigh thymocytes from HoilDCd4 compared with WT mice
(Fig. 6b). Reduced expression of many core NF-kB target genes
was a common feature of thymocytes from HoilDCd4 and
Sharpincpdm mice. These included genes involved in negative
feedback (for example, Nfkbia (or IkBa), Nfkbie (or IkBe), Birc3
(or cIAP2) and Tnfaip3 (or A20)) and T-cell differentiation
(particularly of FOXP3þ Treg cells; for example, Gadd45b, Il2ra,
Tnfrsf18, Tnfrsf4 (or OX40) and Relb; Fig. 6b). To determine
whether there was a defect in the induction of NF-kB target genes
in the LUBAC-deﬁcient strains during the differentiation from
CD69þ MHC Ilow into CD69þ MHC Ihigh thymocytes, we
ﬁrst identiﬁed 154 NF-kB target genes that were signiﬁcantly
up- or downregulated during this transition in WT cells. Barcode
enrichment plots show that, despite the dampened transcription
of NF-kB target genes, the magnitude and direction of changes
induced in these transcripts during the post-positive selection
stages was maintained in HOIL- and SHARPIN-deﬁcient cells
(Supplementary Fig. 4). These ﬁndings support our earlier data
showing that, although LUBAC-deﬁcient thymocytes have
impaired NF-kB signalling, this defect does not by itself explain
the block in thymocyte differentiation observed in HoilDCd4 and
HoipDCd4 mice.
We therefore focused on transcriptional changes that were
observed in thymocytes from HoilDCd4 mice (where differentia-
tion was blocked), but not Sharpincpdm mice (where conventional
thymocyte differentiation proceeds normally). This ﬁlter revealed
that genes involved in cytokine signalling were prominent;
HOIL-deﬁcient thymocytes failed to upregulate Il7r and
downregulate Cish (encoding the SOCS family member, CIS, an
inhibitor of IL-2 signalling), Il2rb and Cxcr4 (Fig. 6c,d).
Consistent with these data, HOIL-deﬁcient thymocytes
appeared to have a speciﬁc defect in an IL-2-sensitive glycolytic
transcriptional programme, with heightened expression of Bcl6
and reduced Myc and Slc2a3 (a regulator of glycolysis), an
apparent parallel with a recent study in mature T-cell
differentiation41. The interferon signalling pathway was also
selectively impaired in HOIL-deﬁcient thymocytes, with reduced
transcription of Stat1, Irf1, Irf7 and Irf9 in CD69þ MHC Ilow
cells (Fig. 6c). Previous studies demonstrating that type I
interferon is a feature of late thymocyte differentiation5, and
that Irf1 is important for thymocyte differentiation42,43, suggest
that these changes may also be critical for the impaired thymocyte
development seen in the HOIL- and HOIP-deﬁcient mice.
In summary, post-positive selection thymocytes from the
LUBAC-deﬁcient strains shared baseline defects in the transcription
of NF-kB targets that may explain the observed Treg cell deﬁciency.
Furthermore, the speciﬁc loss of transcripts in a number of essential
signal transduction pathways from HOIL-1-deﬁcient cells is likely
to account for their block in late-stage thymic T-cell differentiation.
LUBAC is essential for Treg cell homeostasis. The thymus of
HoipDCd4, HoilDCd4 and Sharpincpdm mice all had equivalent
reductions in ‘wave 2’ cells, Treg cell precursors and mature Treg
cells, yet only SHARPIN-deﬁcient mice had substantial numbers
of peripheral Treg cells (Figs 1 and 2). To determine whether the
absence of Treg cells in HoipDCd4 mice was merely secondary to
the loss of conventional T cells in the periphery resulting in
reduced levels of IL-2 (an essential cytokine for the maintenance
of Treg cells) or whether this phenotype reﬂected an
ongoing requirement for LUBAC activity for Treg cell
homeostasis, we created male Foxp3Cre/y; Rnf31ﬂ/ﬂ and female
Foxp3Cre/Cre; Rnf31ﬂ/ﬂ mice (both termed HoipDFoxp3 hereafter).
Mice of the control genotypes remained healthy and survived
beyond 60 days of age, but all HoipDFoxp3 mice developed a severe
wasting disease and died around weaning (Fig. 7a–c). HoipDFoxp3
mice exhibited severe immune pathology, including lymphade-
nopathy, lymphocytic perivascular inﬁltration and tissue
destruction of the lung, liver and exocrine pancreas, hyper-IgE
production and abnormally high numbers of activated CD4þ
and CD8þ T cells (CD44highCD62LlowKI-67þ ; Fig. 7d–h and
Supplementary Fig. 5a–c). These features are all hallmarks of the
Foxp3-deﬁcient scurfy mouse phenotype44.
Although we observed normal proportions of thymic FOXP3þ
Treg cells among CD4SP in HoipDFoxp3 mice, there was a marked
decrease in the numbers and proportions of CD4þ Treg cells in
the spleen and lymph nodes (Fig. 7i and Supplementary
Fig. 5d,e). To determine whether there was a cell intrinsic
requirement for HOIP in peripheral Treg cells, we took advantage
of the fact that the Foxp3YFPCre knock-in allele is X-linked45 to
create chimeras in heterozygous Foxp3Cre/þ females through
X-inactivation. Although we could recover a substantial fraction
of YFPþ Treg cells from the periphery of Foxp3Cre/þHoipﬂ/þ
control mice, very few YFPþ Treg cells were detected in
Foxp3Cre/þHoipﬂ/ﬂ females (Supplementary Fig. 5f,g). Treg cell
loss in HoipDFoxp3 mice could not be rescued by repeated
anti-TNF treatment of neonatal mice commencing from day 5
(data not shown), suggesting that this defect was not caused by
excessive TNF-induced cell death. These ﬁndings establish that
ongoing LUBAC activity is required for the maintenance of
mature Treg cells, with a greater reliance on HOIP activity than
SHARPIN.
Nevertheless, a deeper examination of the peripheral Treg cell
compartment of Sharpincpdm mice revealed substantial
homeostatic perturbation, with markedly increased numbers of
proliferating (Ki-67þ ) Treg cells, elevated expression of CTLA-4
(a key Treg cell effector molecule46), increased proportions of
effector Treg cells (CD44highCD62Llow) and reduced expression
of the pro-survival protein, BCL-2 (Fig. 7j).
Discussion
These data reveal an essential, cell intrinsic role for LUBAC in
multiple aspects of T-cell differentiation. HOIP and HOIL-1 were
required for the differentiation of conventional abT cells,
FOXP3þ Treg cells and NKT cells in the thymus (in HoipDCd4
and HoilDCd4 mice) and maintenance of Treg cells in the
periphery (in HoipDFoxp3 mice). These ﬁndings suggest that the
T-cell deﬁciency observed in patients with loss-of-function
mutations affecting HOIL and HOIP is a primary defect22,23.
The thymic phenotypes caused by loss of HOIL or HOIP are
reminiscent of those observed with T-cell-speciﬁc deletion of
NEMO47 or TAK1 (refs 5,48,49) and align well with the
interactions described between LUBAC and these components
of NF-kB signalling13,14,50. However, constitutive activation of
the NF-kB pathway only partially rescued these defects in
HOIP-deﬁcient thymocytes, suggesting additional roles for
LUBAC in thymocyte differentiation.
By contrast, SHARPIN deﬁciency had a relatively mild impact
on T-cell differentiation; SP maturation was normal but HELIOS
upregulation in CD4SP was impaired, and numbers of Treg
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Figure 6 | Transcriptional impact of LUBAC deﬁciency on T-cell differentiation. (a) Venn diagrams of the numbers of genes upregulated (red) or
downregulated (blue) in comparisons of CD69þ MHC Ilow or CD69þ MHC Ihigh thymocytes from HoilDCd4 versus WT (green) and Sharpincpdm versus WT
(orange) at a 5% false discovery rate (FDR) cutoff. (b) Heatmaps of individual log-expression values. Left plot shows the 25 most upregulated genes and 50 most
downregulated genes for HoilDCd4 versus WT in CD69þ MHC Ilow thymocytes. Right plot show the same for CD69þ MHC Ihigh. Genes are ordered by P-value.
Red indicates relatively higher expression and blue indicates relatively lower expression. Genes highlighted in green are involved in NF-kB signalling, those in yellow
are involved in thymocyte/Treg cell differentiation. Shpncpdm refers to Sharpincpdm mice. (c,d) Genes that are differentially expressed in HoilDCd4 versus WT but
show no change or opposite change in Sharpincpdm. Results for CD69þ MHC Ilow thymocytes are shown in c and CD69þ MHC Ihigh thymocytes in d. The plot
shows the limma t-statistics for each gene for assessing differential expression; the dotted line indicates the 5% FDR cutoffs of t¼ 3.25 for c and t¼ 3.94 for d.
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precursors and differentiated thymic FOXP3þCD25þ Treg cells
markedly reduced. These distinct phenotypes are likely to reﬂect
the relative roles of HOIP and SHARPIN in linear ubiquitination;
loss of HOIP completely ablates linear ubiquitination following
TNF stimulation, yet SHARPIN deﬁciency only partially
impairs LUBAC activity (refs 17–19, our unpublished data).
Thus, HOIL-1/HOIP complexes would sustain sufﬁcient LUBAC
function to support conventional thymocyte and NKT cell
differentiation, yet optimal LUBAC activity (including
SHARPIN) is necessary for the Treg cell sub-lineage, which is
more heavily reliant on NF-kB signals6.
LUBAC is likely to coordinate signals from several stimuli
essential for T-cell differentiation. Although a role for LUBAC in
mediating B-cell receptor- and TCR-driven NF-kB signals
via interactions with the CBM has been described34,35, the
normal T-cell differentiation observed in CARD11-, BCL10- or
MALT1-deﬁcient mice (for example, see ref. 36) and our data
showing that constitutive active IKK2 cannot restore peripheral T
cells suggest that there are other LUBAC-dependent signals
downstream of the TCR that are required for SP thymocyte
maturation. Indeed, a role for SHARPIN has been implicated in
JNK and ERK activation downstream of TCR signals25,26. Another
possibility is that LUBAC is required to transduce signals from
other cell surface receptors critical for SP maturation, such as
members of the TNFR superfamily. This scenario may be
particularly pertinent to the defects observed in HELIOS
upregulation and thymic Treg differentiation. GITR, TNFR2 and
OX40 play important, redundant roles in the intra-thymic
differentiation of Treg cells that have received high afﬁnity TCR
signals8. Our data indicating that LUBAC has an important role in
TNFR signalling in thymocytes support the notion that TNFR
superfamily signals might also be important for the ﬁnal stages of
conventional T-cell differentiation in the thymus.
In this context, an important LUBAC function in several cell
types is the inhibition of death receptor-mediated apoptosis or
necroptosis. SHARPIN deﬁciency can predispose cells to
caspase-8-dependent apoptosis or necroptosis, the latter via a
pathway involving RIP3K and MLKL in cells receiving TNF
signals17. Several lines of evidence suggest that induction of these
cell death pathways does not account for the T-cell developmental
defects we observed: (1) simultaneous genetic ablation of both of
these cell death pathways did not rescue the impaired generation
of thymic Treg cells in Sharpincpdm mice or the block in
conventional thymocyte differentiation in HoipDCd4 mice;
(2) HOIL-1-, HOIP- and SHARPIN-deﬁcient thymocytes were
not predisposed to TNF-induced cell death; (3) pharmacologic
inhibition of apoptosis or necroptosis did not alter thymocyte
viability; and (4) TNF blockade in vivo did not rescue thymocyte
differentiation in HoipDCd4 mice or the loss of Treg cells in
HoipDFoxp3 mice. These data contrast recent ﬁndings that
TNF deﬁciency could restore late thymocyte differentiation in
IKK-deﬁcient mice51 or TAK1-deﬁcient mice5 and suggest roles
for LUBAC beyond inhibiting TNF-induced cell death. In
addition, the failure of combined BAX/BAK deletion to rescue
SP thymocyte maturation in HoipDCd4 mice provides evidence
that LUBAC activity is not required to antagonize thymocyte
deletion triggered by BH3-only proteins or to mediate cytokine-
derived survival programmes (such as IL-7 or IL-2), stimuli that
affect the mitochondrial pathway of apoptosis. Although we
cannot exclude that alternative cell death pathways might be
activated in LUBAC-deﬁcient thymocytes, it is likely to be that
LUBAC transduces other signals necessary for the transcriptional
programmes guiding conventional T-cell and Treg cell
differentiation in the thymus.
The partial rescue of thymocyte maturation observed in
HoipDCd4IKKca mice suggests that LUBAC-mediated NF-kB
activation is important, but not sufﬁcient to drive the ﬁnal stages
of thymocyte differentiation. Our transcriptional analysis
comparing postpositive selection thymocytes from HoipDCd4
and Sharpincpdm mice suggests a prominent role for pathways
regulating cytokine responsiveness and metabolic ﬁtness. Further
studies will establish how LUBAC activity inﬂuences these
pathways, but it is likely to be that this role also extends to
peripheral Treg cell homeostasis. The deletion of HOIP following
the thymic differentiation of FOXP3þ cells caused near-complete
loss of peripheral Treg cells, establishing a cell intrinsic
requirement for ongoing LUBAC activity in this lineage. The
kinetics of the ensuing immunopathology was much swifter
compared with that observed in mice lacking the pro-survival
BCL-2 family member, MCL-1, speciﬁcally in Treg cells52, but
was similar to that seen in Foxp3-deﬁcient scurfy mutant mice44.
This ﬁnding indicates an acute requirement for continued
LUBAC-dependent signalling in Treg cells following their
export to the periphery.
We conclude that LUBAC is essential for coordinating multiple
signals required for the differentiation and homeostasis of
conventional and non-conventional T-cell types required for
adaptive immunity and tolerance.
Methods
Mice. The generation of CD4Cre, Foxp3Cre, R26StopFLikk2ca, Bax-ﬂoxed, Bak /
and Rnf31-ﬂoxed mice were previously described18,37,45,53–55. Rbck1DCd4, Rnf31DCd4,
Rosa26-ikk2ca, Rnf31DCd4BaxDCd4Bak / , Rnf31DCd4Casp8DCd4Mlkl / ,
Rnf31DFoxP3, Mlkl / , Mlkl /Casp8 / , SharpincpdmCasp8 /Mlkl / ,
Rip3 /Casp8þ / , SharpincpdmRip3 /Casp8þ / , Tnf / and
SharpincpdmTnf / mice were generated or backcrossed onto the C57BL/6
background from foundation strains. Rosa26-ikk2ca mice were obtained from
Jackson Laboratories. Sharpincpdm mice on a C57BL/Ka background were
obtained from Jackson Laboratories and were backcrossed onto the C57BL/6
background twice. All mice were housed at The Walter and Eliza Hall Institute
of Medical Research (WEHI) under speciﬁc pathogen-free conditions.
Experiments were performed in compliance with ethical regulations and were
approved by the Animal Ethics Committee guidelines of the Melbourne Research
Directorate.
Figure 7 | LUBAC is required for peripheral Treg cell homeostasis and tolerance. (a) Kaplan–Meyer survival curve measured from birth to 60 days for
mice of the indicated genotypes (Po0.0001 using the log-ranked Mantel–Cox test). (b) Weights of 18–22-day-old male and female HoipDFoxp3 mice
and healthy littermate controls. (c) Runted appearance and (d) lymphadenopathy observed in HoipDFoxp3 mice, with mean cell number indicated.
(e) Representative hematoxylin and eosin (haematoxylin and eosin) stained sections of lung, liver and pancreas of 21-day-old mice of the indicated
genotypes (scale bars, 500mm). (f) Plasma IgE concentrations in 18–22-day-old HoipDFoxp3 mice and healthy littermate controls. (g) Expression of CD44
and CD62L on CD4þFOXP3 (top panel) and CD8þ T cells (bottom panel) in spleens of WT and HoipDFoxp3 mice. (h) Absolute numbers of
CD44highCD62Llow activated cells in the CD4þFOXP3 and CD8þ population of WT and HoipDFoxp3 mice. (i) Representative ﬂow cytometry plots and
absolute numbers of FOXP3þTCRbþ cells in the thymus (top panel), spleen (middle panel) and lymph nodes (bottom panel) of WTand HoipDFoxp3 mice.
(j) Expression of Ki-67, CTLA-4, CD62L and BCL-2 in CD4þFOXP3þ cells in the spleen from WT (grey shaded histogram) and Sharpincpdm (black thick
histogram) mice. Shpncpdm refers to Sharpincpdm mice. (n¼ 6–9 per /genotype, bar graphs show mean±s.d.). *Po0.05, **Po0.01, ***Po0.005 and
****Po0.001, respectively. One-way analysis of variance with a Tukey’s post-hoc test for multiple comparisons was used for statistical analysis. Data are
pooled from (a,b,f,g,h) or representative (c–e) of three independent experiments with one to three mice per group.
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Generation of Rbck1 ﬂoxed mice. The targeting construct was designed to
introduce loxP sites on either side of a 1.5 kb genomic fragment containing Rbck1
promoter and exons 1 and 2 (exon 2 contains the ATG start codon), as well as a
FRT-ﬂanked PGK-hygromycin resistance cassette for screening purposes
(Supplementary Fig. 6). The targeting construct was electroporated into
C57BL/6-derived Bruce-4 embryonic stem (ES) cells56. Homologous
recombination events were identiﬁed by Southern blotting and blotting with a
hygro-speciﬁc probe was used to conﬁrm single-construct integration. A correctly
targeted ES cell clone was injected into blastocysts, resulting in the gene-targeted
mouse strain. The hygromycin-resistance cassette was deleted by crossing the
resultant Hoil1-ﬂoxed heterozygous mice with C57BL/6-ﬂpe-transgenic
mice and the ﬂpe transgene was subsequently eliminated by crossing offspring
to C57BL/6 mice. All of the mice analysed were devoid of hygro and ﬂpe. WT
and ﬂoxed alleles were discriminated by a PCR with primers Hoil-Fwd
50-ACCCTAGGCCTAGTCAGTGCAAA-30 and Common-Hoil-Rev
50-AGGCTGTGGTCCATTCTAGCCAT-30 producing bands of 485 bp (WT) and
601 bp (ﬂoxed). The mutant allele after cre deletion was detected by PCR using
Common-Hoil-Rev and Hoil-cre 50-CCCTACAGCTAATTTTTGCAGAT
GTCAGG-30 producing a 901 bp band. PCR conditions were: 95 C 3min, then
33 cycles 95 C, 30 s, 55 C, 20–30 s, 72 C, 60 s.
Bone marrow chimeras. To generate haematopoietic chimeras, C57/BL6.CD45.1/
CD45.5.2 recipient mice were irradiated with two doses of 5.5 Gy given 3 h
apart and then intravenously injected with 4 106 T-cell-depleted bone marrow
cells from CD45.2 experimental mice alone or mixed at a ratio of 1:1 with
C57/BL6.CD45.1 WT bone marrow cells. Mice received 100mg of anti-Thy1 mAb
(clone T24) intraperitoneally 24 h after injection of bone marrow cells, to eliminate
residual donor cells, then were allowed to reconstitute for 8–10 weeks before
analysis.
Flow cytometry. Single-cell suspensions of various lymphoid tissues were stained
with ﬂuorochrome or biotin conjugates, to detect the cell surface and intracellular
proteins. Antibodies to cell surface proteins were purchased from BioLegend,
except where indicated: CD4 (clone GK1.5), CD8 (clone 53-6.7), CD25
(clone PC61.5), TCRb (clone H57-597), CD44 (clone IM7), CD62L (clone
MEL-14), H2-Kb (clone AF6-88.5), CD69 (clone H1.2F3), CD24 (clone M1/69),
CCR7 (clone 4B12), Helios (clone 22F6), TCRgd (clone GL3), NK1.1
(clone PK136), B220 (WEHI, clone RA3-6B2), MHC II (WEHI, clone M15/114),
Mac-1 (WEHI, clone M1/70), Gr-1 (WEHI, clone RB6-8C5), CD45.1 (WEHI,
clone AL14A2), CD45.2 (clone 104), Ki-67 (BD Biosciences, clone BD56), CD152
(clone UC10-4B9), BCL2 (clone BCL/10C4) and FOXP3 (eBiosciences, clone
FJK-16). Monomers of biotinylated mouse CD1d-PBS44 (a-GalCer analogue with a
C24:1 acyl chain were tetramerized with streptavidin conjugated to phycoerythrin
(BD Pharmingen). Staining for CCR7 was done for 60min at 37 C in pre-warmed
FACS buffer (PBS containing 1% vol/vol heat-inactivated bovine serum and 5mM
EDTA). All other surface stains were incubated for 30min at 4 C. Intracellular
staining for FOXP3, Ki67, BCL2 or Helios was performed after ﬁxation and
permeabilization using the reagents from the eBiosciences FOXP3 staining kit.
Sample data were acquired on an LSRII or Fortessa ﬂow cytometer
(BD Biosciences) and analysed using FlowJo software (TreeStar).
Western blotting. Unfractionated thymocytes were stimulated for various periods
of time with plate-bound monoclonal 10 mgml 1 anti-CD3 (WEHI Monoclonal
Antibody Facility, clone 145-2C11)þ 10mgml 1 anti-CD28 (WEHI, clone 37N51)
or 100 ngml 1 Fc-TNF (WEHI). Cells were washed twice in PBS before lysate
preparation. Cell lysates were prepared in DISC buffer (1% NP-40, 10% glycerol,
150mM NaCl, 20mM Tris pH 7.5, 2mM EDTA, Roche complete protease
inhibitor cocktail, 2mM sodium orthovanadate, 10mM sodium ﬂuoride,
b-glycerophosphate and N2O2PO7). Cell lysates were loaded in NuPAGE Bis-Tris
gels (Life Technologies, Mulgrave, VIC, Australia) and transferred onto
Immobilon-P poly(vinylidene diﬂuoride) membranes (Millipore, Billerica, MA,
USA) or Hybond-C Extra (GE Healthcare). Membranes were blocked and
antibodies were diluted in 5% skimmed milk powder or BSA in 0.1% Tween-20/
NaCl/Pi or NaCl/Tris. Antibodies against phospho-p65 (Cell Signalling
Technologies, clone 93H1, 1:1,000), phospho-p38 (Cell Signalling Technologies,
clone D3F9, 1:1,000), IkBa (Cell Signalling Technologies, cat number #9242,
1:1,000), b-actin (Sigma Aldrich, clone AC-15, 1:5,000) were used for western
blotting. Signals were detected by chemiluminescence (Millipore) after incubation
with secondary antibodies conjugated to horseradish peroxidase. Images have been
cropped for presentation. Full-sized images are presented in Supplementary Fig. 7.
In vitro cell death assay. Cells cultured in 96-well tissue culture plates were
harvested 24h after stimulation with Fc-TNF (WEHI)/SMAC-mimetic Compound
A (GT12911, TetraLogic Pharmaceuticals) with or without QVD-OPh (MP Bio-
medicals)/necrostatin-1 (TetraLogic Pharmaceuticals) and cell death was measured
by propidium iodide (PI) staining. Flow cytometry was performed on a LSRII or
Fortessa ﬂow cytometer (BD Biosciences) and data were analysed using FlowJo
software (TreeStar).
Measurement of serum IgE. Serum IgE (1:10 dilution) was measured by ELISA
using 2 mgml 1 rat anti-mouse Ig antibodies (Southern Biotech, clone 23G3) as a
capture reagent and developed with 1:500 mouse Ig isotype-speciﬁc goat anti-
mouse IgE (Fc speciﬁc) conjugated to horseradish peroxidase (Nordic MUBio)57.
Capture reagent was applied overnight at 4 C, sera was applied for 4 h at room
temperature and ELISA plates were developed in the dark for 45min at room
temperature. IgE isotype monoclonal anti-dinitrophenyl antibody produced in
mouse, IgE isotype (Sigma, MO, clone SPE-7) were used as standards.
RNA sequencing. Thymocytes were prepared from three mice of each genotype
(WT, HoilDCd4 and Sharpincpdm), and CD69þ MHC Ilow and CD69þ MHC Ihigh
cells were FACS puriﬁed on a MoFlo cell sorter (Beckman Coulter), with a dump
channel to gate out PIþ , CD25þ , CD44þ , NK1.1þ , B220þ , MHC IIþ , Gr1þ ,
Mac-1þ and dTCRþ cells. Sorted cells were preserved in RNAlater (ThermoFisher
Scientiﬁc) and frozen at  80 C, then RNA was isolated with RNeasyPlus Mini kit
(Qiagen). Messenger RNA reverse transcription and complementary DNA libraries
were prepared using the TruSeq RNA Sample preparation kit (Illumina) following
the manufacturer’s instructions. Indexed sample libraries were subjected to 75 base
single-end sequencing using the 75 cycle high-output kit v2 chemistry for the
NextSeq 500 sequencing instrument (Illumina).
Bioinformatics analysis. Sequencing reads were mapped to the mouse genome
(mm10) using the subread aligner58 implemented in the Rsubread software
package. Gene-level read counts were obtained using featureCounts59 and its
inbuild mm10 annotation, which includes Entrez gene ID, chromosome and gene
length information, corresponding to the NCBI RefSeq annotations. Gene
annotation was obtained from the NCBI Mus musculus gene info ﬁle (downloaded
25 September 2015). Statistical analysis used the edgeR60 and limma61 software
packages. Genes were ﬁltered as not expressed if they failed to show at least 0.5
count per million reads in at least 3 samples. As there are female and male mice in
this experiment, genes from chromosome Y and the gene Xist were ﬁltered out so
as to correct for gender effect. Predicted genes and the genes without ofﬁcial gene
symbols were also ﬁltered out. TMM scale normalization62 was applied and read
counts were transformed to log2 counts per million with a prior count of 1 using
the edgeR cpm function. Linear models were used to test for expression differences
between different genotypes. Empirical array quality weights were estimated to
allow for differences in quality between the RNA samples63. Each mouse was
treated as a random block, allowing for correlation between CD69þ MHC Ilow and
CD69þ MHC Ihigh cells from the same mouse64. Differential expression between
genotypes were assessed using empirical Bayes moderated t-statistics, allowing for
an abundance trend in the s.e. and for robust estimation of Bayesian
hyperparameters65. The Benjamini and Hochberg method66 was used to adjust the
P-values so as to control the false discovery rate.
A list of NF-kB target genes was obtained from http://www.bu.edu/nf-kb/gene-
resources/target-genes. A number of steps were required to convert the various
gene identiﬁers to mouse Entrez Gene IDs. Where possible, gene aliases were
converted to current ofﬁcial human gene symbols using the Bioconductor
annotation package, org.Hs.eg.db. Otherwise, human RefSeq accession numbers
were converted to human symbols using org.Hs.eg.db and mouse RefSeq accession
numbers were converted to mouse Entrez Gene IDs using org.Mm.eg.db. Finally,
human symbols were mapped to mouse Entrez Gene IDs using the Jackson
Laboratory mouse–human orthologue table downloaded December 2012 (ref. 67)
and the NCBI mouse–human homologue table downloaded August 2013. NF-kB
target genes that were differentially expressed at 5% false discovery rate between
CD69þ MHC Ihigh versus CD69þ MHC Ilow cells in WT mice were then used for
gene-set testing between CD69þ MHC Ihigh versus CD69þ MHC Ilow in Sharpin
and between CD69þ MHC Ihigh versus CD69þ MHC Ilow in HOIL-1. Gene-set
testing was conducted using limma’s roast function68, with 9,999 residual rotations
and the same linear model settings as for the differential expression analysis.
Barcode enrichment plots were produced using limma’s barcode plot function.
Statistical analysis. Statistical comparisons were made using one-way analysis of
variance with a Tukey’s post-hoc test for multiple comparisons with Prism v.6.0
(GraphPad). P-values o0.05 were considered to indicate a statistically signiﬁcant
difference.
Data availability. Sequence data that support the ﬁndings of this study have been
deposited in GEO with the primary accession code GSE74552. All additional data
supporting the ﬁndings of this study are available within this article and its
Supplementary Information ﬁles or from the corresponding author on a reasonable
request.
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